MedTrace Logo

Uterine Artery Embolization With Microspheres in Patients With Leiomyoma.

NCT03535610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-09-04

No results posted yet for this study

Summary

To evaluate the therapeutic response to uterine artery embolization in 30 patients with leiomyoma using the microspheres Embosoft (Embosoft® - Scitech Medical).

Conditions

  • Uterine Leiomyoma

Interventions

DEVICE

Uterine Embolization

Uterine Embolization with PVA Microspheres

Sponsors & Collaborators

  • Scitech Produtos Medicos Ltda

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-13
Primary Completion
2020-02-20
Completion
2020-05-20

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535610 on ClinicalTrials.gov